Literature DB >> 25713907

Early recurrence in large hepatocellular carcinoma after curative hepatic resection: prognostic significance and risk factors.

Li Zhou, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu.   

Abstract

BACKGROUND/AIMS: So far, prognostic significance and risk factors of early recurrence after curative resection in large hepatocellular carcinoma (LHCC) remain unclear. The present study aimed to answer these questions.
METHODOLOGY: Clinical, pathologic and follow-up data of consecutive 116 patients with LHCC (>5cm) after curative resection were collected and analyzed. The recurrence pattern of LHCC was also compared with that of 55 patients with small HCC (SHCC, ≤5cm).
RESULTS: Forty-five patients (38.8%) with LHCC developed recurrence within 1 year after surgery (defined as early recurrence), with a significantly higher ratio contrast to those with SHCC. Univariate analysis showed that age, HBsAg positivity, satellite nodule, TNM stage, resection extent and early recurrence served as significant indicators of post-recurrence overall survival in recurrent LHCC. In addition, only early recurrence was proven to be significant in multivariate Cox regression test. On the other hand, age, HBsAg positivity, portal vein tumor thrombosis, microvascular invasion, TNM stage, Edmondson-Steiner grade and resection extentwere related to early recurrence in LHCC. Among them, microvascular invasion and Edmondson-Steiner grade were independent predictors.
CONCLUSIONS: Patients with early recurrence carried very poor post-recurrence prognosis in LHCC. The microvascular involvement and differentiation grade might be particularly helpful for prediction of early recurrence.

Entities:  

Mesh:

Year:  2014        PMID: 25713907

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection.

Authors:  Qiang Lu; Qing-Shan Li; Wei Zhang; Kang Liu; Tao Li; Jia-Wei Yu; Yi Lv; Xu-Feng Zhang
Journal:  Ann Surg Treat Res       Date:  2020-06-29       Impact factor: 1.859

2.  A national report from China Liver Transplant Registry: steroid avoidance after liver transplantation for hepatocellular carcinoma.

Authors:  Qiang Wei; Feng Gao; Runzhou Zhuang; Qi Ling; Qinghong Ke; Jian Wu; Tian Shen; Mangli Zhang; Min Zhang; Xiao Xu; Shusen Zheng
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

3.  Lrig1 is a positive prognostic marker in hepatocellular carcinoma.

Authors:  Bo Yang; Chen Dai; Rumeng Tan; Bo Zhang; Xiao Meng; Jing Ye; Xinqiang Wang; Lai Wei; Fan He; Zhishui Chen
Journal:  Onco Targets Ther       Date:  2016-11-15       Impact factor: 4.147

4.  Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma.

Authors:  Zhenpeng Peng; Mengjie Jiang; Huasong Cai; Tao Chan; Zhi Dong; Yanji Luo; Zi-Ping Li; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430

Review 5.  Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.

Authors:  Archana Rastogi
Journal:  World J Gastroenterol       Date:  2018-09-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.